NECTAR LIFESCIENCES
Back to Income Statement
|
NECTAR LIFESCIENCES Last 5 Year Consolidated Net Profit History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Consolidated Net Profit | ₹-114 Cr | ₹5.00 Cr | ₹-24 Cr | ₹25 Cr | ₹-73 Cr |
What is the latest Consolidated Net Profit of NECTAR LIFESCIENCES ?
| Year | Consolidated Net Profit |
|---|---|
| Mar2025 | ₹-114 Cr |
| Mar2024 | ₹5.00 Cr |
| Mar2023 | ₹-24 Cr |
| Mar2022 | ₹25 Cr |
| Mar2021 | ₹-73 Cr |
How is Consolidated Net Profit of NECTAR LIFESCIENCES Trending?
| Years | Consolidated Net Profit | % Change | |
|---|---|---|---|
| Mar2025 | ₹-114 Cr | Negative | |
| Mar2024 | ₹5.00 Cr | Positive | |
| Mar2023 | ₹-24 Cr | Negative | |
| Mar2022 | ₹25 Cr | Positive | |
| Mar2021 | ₹-73 Cr | - | |
Compare Consolidated Net Profit of peers of NECTAR LIFESCIENCES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| NECTAR LIFESCIENCES | ₹236.5 Cr | -0.7% | 10.9% | -45.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹399,549.0 Cr | -1.9% | -7.3% | -2.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹166,862.0 Cr | 1.8% | 3.3% | 9.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹139,912.0 Cr | -0.5% | -4% | 29.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹101,891.0 Cr | 0.2% | -4.9% | 6.6% | Stock Analytics | |
| CIPLA | ₹99,591.5 Cr | 0.5% | -3.8% | -17% | Stock Analytics | |
NECTAR LIFESCIENCES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| NECTAR LIFESCIENCES | -0.7% |
10.9% |
-45.8% |
| SENSEX | 3.2% |
5% |
5.5% |
You may also like the below Video Courses